Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PharmaGap and Queen's University collaborate to develop GAP-107B8 for bladder cancer

Dec. 29, 2010

Telapristone shows promise in preclinical models of breast cancer

Dec. 29, 2010

Exelixis divulges novel mTORC1 inhibitors

Dec. 29, 2010

New inhibitors of insulin-like growth factor 1 receptor presented

Dec. 29, 2010

AKN-028 significantly alters gene expression profiles of AML cells

Dec. 29, 2010

PI3K-alpha inhibitor PIK-75 induces apoptosis of AML cells

Dec. 29, 2010

EMA to review Allos' MAA for Folotyn in relapsed or refractory PTCL

Dec. 28, 2010

Vertex Pharma patents new inhibitors of hepatocyte growth factor receptor

Dec. 28, 2010

New CREB-1 inhibitor XX-650-23 shows promise to treat AML

Dec. 28, 2010

Enrollment completed in phase II study of belinostat in carcinoma of unknown primary

Dec. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...